Evidence map›Paper›PMID 41383850›Full record

ArticleFrontiers in cellular and infection microbiology2025

The impact of sublethal antimicrobial blue light on lipidomic changes of

Jiaxin Wu, Xuan Lu, Ming Huang, Shuyan Wu, Maomao Zeng, Zhaojun Liu, Keyang Yu, Xiujuan Zhang, Xiaoying Sun, Xiaoyuan Wang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jiaxin WuSchool of Biotechnology, Jiangnan University, Wuxi, China.
Xuan LuSchool of Biotechnology, Jiangnan University, Wuxi, China.
Ming HuangSchool of Biotechnology, Jiangnan University, Wuxi, China.
Shuyan WuAgResearch Ltd., Hopkirk Research Institute, Massey University, Palmerston North, New Zealand.
Maomao ZengSchool of Biotechnology, Jiangnan University, Wuxi, China.
Zhaojun LiuSchool of Biotechnology, Jiangnan University, Wuxi, China.
Keyang YuSchool of Biotechnology, Jiangnan University, Wuxi, China.
Xiujuan ZhangSchool of Biotechnology, Jiangnan University, Wuxi, China.
Xiaoying SunSchool of Biotechnology, Jiangnan University, Wuxi, China.
Xiaoyuan WangSchool of Biotechnology, Jiangnan University, Wuxi, China.
Xiaoqing HuSchool of Biotechnology, Jiangnan University, Wuxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial blue light (aBL) is an effective non-thermal disinfection method against foodborne bacterial pathogens. While aBL-induced oxidative stress is known to cause cell membrane damage, its specific effects on bacterial lipid composition remain poorly understood. This study investigated aBL-triggered lipidomic changes in two major foodborne pathogens (Escherichia coli and Salmonella Typhimurium). We identified more than 70 lipid species across 6 classes, with over 50% showing significant variations in profile, intensity, and degree of unsaturation following aBL exposure. Phosphatidylethanolamine (PE) species exhibited the most pronounced alterations. Notably, both strains demonstrated decreased unsaturated lipid intensity alongside increased malondialdehyde levels-a key oxidative stress marker. These findings provide crucial insights into bacterial lipid dynamics under aBL stress and advance our understanding of the molecular mechanisms behind aBL-mediated bacterial inactivation.

Indexed as

Escherichia coliLightLipid MetabolismLipidomicsLipidsSalmonella typhimuriumBlue LightMalondialdehydeOxidative StressPhosphatidylethanolaminesLipidsMalondialdehydephosphatidylethanolaminePhosphatidylethanolaminesantimicrobial blue lightEscherichia colilipidomicsSalmonella Typhimuriumunsaturated lipids

Identifiers

PMID41383850
PMCPMC12689863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.